Role of adjuvant therapy in the management of pancreatic cancer

Advances in Surgery

Volumn 39, Issue , 2005, Pages 223-244

  Laheru, Dan ^a   Yeo, Charles J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 28444438908     PISSN: 00653411     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yasu.2005.05.003     Document Type: Article

References (41)

1. Sohn TA, Yeo CJ, Cameron JL, et al: Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4:567-579, 2000.
2. Yeo CJ, Yeo TP, Hruban RH, et al: Cancer of the pancreas, in DeVita FT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, ed 7. Philadelphia, Lippincott Williams and Wilkins, pp 945-986, 2005.
3. Kalser MH, Ellenberg SS: Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120:899-903, 1985.
4. Gastrointestinal Tumor Study Group: Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59:2006-2010, 1987.
5. Whittington R, Bryer MP, Haller DG, et al: Adjuvant therapy of resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 21:1137-1143, 1991.
6. Foo ML, Gunderson LL, Nagorney DM, et al: Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation ± 5 fluorouracil. Int J Radiat Oncol Biol Phys 26:483-489, 1993.
7. Spitz FR, Abbruzzese JL, Lee JE, et al: Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 15:928-937, 1997.
8. Yeo CJ, Abrams RA, Grochow LB, et al: Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoradiation improves survival. Ann Surg 225:621-636, 1997.
9. Demeure MJ, Doffek KM, Komorowski RA, et al: Molecular metastases in stage I pancreatic cancer: Improved survival with adjuvant chemoradiation. Surgery 124:663-669, 1998.
10. Pendurthi TK, Hoffman JP: Pre-operative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma. Am Surg 64:686-695, 1998.
11. Abrams RA, Grochow LB, Chakravarthy A, et al: Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: Survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels. Int J Radiat Oncol Biol Phys 44:1039-1046, 1999.
12. Klinkenbijl JH, Jeekel J, Sahmoud T, et al: Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region. Ann Surg 230:776-784, 1999.
13. Paulino AC: Resected pancreatic cancer treated with adjuvant radiotherapy with or without 5-fluorouracil: Treatment results and patterns of failure. Am J Clin Oncol 22:489-498, 1999.
14. Mehta VK, Fisher GA, Ford JM, et al: Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer. Int J Radiat Oncol Biol Phys 48:1483-1487, 2000.
15. Nukui Y, Picozzi VJ, Traverso LW: Interferon based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg 179:367-371, 2000.
16. Chakravarthy A, Abrams RA, Yeo CJ: Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: Acceptable toxicity and suggestion of improved 1 year survival. Int J Radiat Oncol Biol Phys 48:1089-1096, 2000.
17. Neoptolemos JP, Dunn JA, Stocken DD, et al: Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: A randomized controlled trial. Lancet 358:1576-1585, 2001.
18. Picozzi VJ, Kozarek RE, Jacobs AD, et al: Adjuvant therapy for resected pancreas cancer (PC) using alpha-interferon (IFN)-based chemoradiation: Completion of a phase II trial. Proc ASCO 22:265A, 2003.
19. Van-Laethem JL, Demols A, Gay F, et al: Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: A phase II study. Int J Radiat Oncol Biol Phys 56:974-980, 2003.
20. Neoptolemos JP, Stocken DD, Friess H, et al: A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350:1200-1210, 2004.
21. Todd KE, Gloor B, Lane JS, et al: Resection of locally advanced pancreatic cancer after downstaging with continuous infusion 5-fluorouracil, mitomycin-C, leukovorin and dipyridamole. J Gastrointest Surg 2:159-166, 1998.
22. Chemotherapy for pancreatic cancer (letter). N Engl J Med 350:2713-2715, 2004.
23. Greten TF, Jaffee EM: Cancer vaccines. J Clin Oncol 17:1047-1060, 1999.
24. Cox AL, Skipper J, Chen Y, et al: Identification of a peptide recognized by five melanoma specific human cytotoxic T cell lines. Science 264:716-719, 1994.
25. Dranoff G, Jaffee EM, Golumbek P, et al: Vaccination with irradiated tumor cells engineered to secrete murine GM-CSF stimulates potent, specific and long lasting anti tumor immunity. Proc Natl Acad Sci U S A 90:3539-3543, 1993.
26. Huang AY, Golumbek PT, Ahmadzadeh M, et al: Role of bone marrow derived cells in presenting MHC class I restricted tumor antigens. Science 264:961-965, 1994.
27. Jaffee EM, Hruban R, Biedrzycki B, et al: A novel allogeneic GM-CSF secreting tumor vaccine for pancreatic cancer: A phase I trial of safety and immune activation. J Clin Oncol 19:145-156, 2001.
28. Iacobuzio-Donahue CA, Maitra A, Shen-Ong GL, et al: Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am J Pathol 160:1239-1249, 2002.
29. Argani P, Iacobuzio-Donahue C, Ryu B, et al: Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: Identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res 3862:3862-3868, 2001.
30. Thomas AM, Santarsiero LM, Lutz ER, et al: Mesothelin-specific CD8(+) T cells responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients. J Exp Med, 200:297-306, 2004.
31. Evans DB, Rich TA, Byrd DR, et al: Pre-operative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg 127:1335-1339, 1992.
32. Hoffman JP, Weese JL, Solin LJ, et al: A pilot study of pre-operative chemoradiation for patients with localized adenocarcinoma of the pancreas. Am J Surg 169:71-78, 1995.
33. Staley CA, Lee JE, Cleary KR, et al: Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg 171:118-125, 1996.
34. Hoffman JP, Lipsitz S, Pisansky T, et al: Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: An Eastern Cooperative Oncology Group study. J Clin Oncol 16:317-323, 1998.
35. Pisters PW, Abbruzzese JL, Janjan NA, et al: Rapid fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. J Clin Oncol 16:3843-3850, 1998.
36. White RR, Hurwitz HI, Morse MA, et al: Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas. Ann Surg Oncol 8:758-765, 2001.
37. Breslin TM, Hess KR, Harbison DB, et al: Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: Treatment variables and survival duration. Ann Surg Oncol 8:123-132, 2001.
38. Moutardier V, Giovanni M, Lelong B, et al: A phase II single institutional experience with pre-operative radiochemotherapy in pancreatic adenocarcinoma. Eur J Surg Oncol 28:531-539, 2002.
39. Arnoletti JP, Hoffman JP, Ross EA, et al: Pre-operative chemoradiation in the management of adenocarcinoma of the body of the pancreas. Am Surg 68:330-335, 2002.
40. Pisters PWT, Wolff RA, Janjan NA, et al: Preoperative paclitaxel and concurrent rapid fractionation radiation for resectable pancreatic adenocarcinoma: Toxicities, histologic response rates and event-free outcome. J Clin Oncol 20:2537-2544, 2002.
41. Magnin V, Moutardier V, Giovannini MH, et al: Neoadjuvant preoperative chemoradiation in patients with pancreatic cancer. Int J Radiat Oncol Biol Phys 55:1300-1304, 2003.